Introduction: Hemophilia is a rare bleeding disorder characterized by deficient clotting factors, which may increase perioperative risks in patients undergoing major cardiac surgery such as coronary ...
SAN FRANCISCO, CA—For patients with failed saphenous vein grafts (SVGs) after CABG, performing PCI to open up the graft appears to be the better course of action over intervening on the bypassed ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
About The Study: Although the incidence of new-onset atrial fibrillation (AF) after coronary artery bypass grafting (CABG) in this study was higher than previously reported, the AF burden in these ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
DURHAM, N.C., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc., a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, ...
Madrid, Spain – 1 September 2025: After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to ...
After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results